Authors of a case study reported severe adult-onset Still disease manifestations in a patient with long-term sequelae of COVID-19.
Junction: Still's Disease
PAH is an under-diagnosed complication of adult-onset Still disease.
Researchers examined the efficacy and safety of tocilizumab in patients with adult-onset Still’s disease.
Next post in JA News Briefs